September 26, 2023   Regulated Bioanalysis Workshop
September 27, 2023   Discovery Bioanalysis and New Technologies Workshop
September 28, 2023   Mechanistic ADME Workshop

Title

Speaker

Company

Time

Registration

 

7:00 - 8:00

Workshop Introduction

8:00 - 8:10 

Session I: State of the FDA - Guidance, Approval, and Beyond

Session Introduction: Lori Payne, Alturas Analytics & James Schiller, Merck

 

 

8:10 - 8:15

FDA Speaker

TBD

FDA

8:15 - 8:45

Plenary Talk - Merck's Strategy Around Decentralized Trials, Bioanalytical Sampling and Logistics

Melanie Anderson

Merck

8:45 - 9:25

Patient Centric Sampling in Therapeutic Development Programs

Joleen White

Bill and Melinda Gates Medical Research Institute

9:25 - 9:55

Title TBA

TBA

Alturas

9:55 - 10:10

Vendor Presentation

10:10 - 10:35

AM Break

10:35 - 10:55

Session II: Emerging Modalities and New Technologies

Session Introduction: Darshana Jani, Moderna & Joe Tweed, Bicycle Therapeutics

 

10:55 - 11:00

Evaluating a Hybrid LC-MS/MS Approach for the Quantification of siRNA Analytes

Karan Agrawal

Janssen Research and Development

11:00 - 11:25

Sponsor Showcase

11:25 - 11:45

Title TBA

Heather Cohen

Bicycle Therapeutics

11:45 - 12:10

RT-qPCR Method Development and Validation for mRNA Analysis

Suresh Paddigari

Moderna

12:10 - 12:35

Lunch

 

12:35 - 1:50

Session III: Immunogenicity Applications for Various Drug Modalities

Session Introduction: Ang  Liu, Daiichi & Fumin Li, Biollege Bioanalytical Consulting

 

1:50 - 1:55

Vaccine Bioanalysis Focused on Immunogenicity

Liang Zhu

Moderna

1:55 - 2:20

Chasing the Matrix Interference in a Bispecific ADA Assay - Divergent Target Interference Based on a Patient Geography

Arkadeep Sinha

EMD Serono

2:20 - 2:45

MAPPS - Title TBA

Anette Karle

Novartis (Switzerland)

2:45 - 3:10

PM Break

3:10 - 3:30

Poster Presentations

     

Session Introduction

 

 

3:30 - 3:35

Rapid Fire Poster Presentations

3:35 - 4:20

Reception and Poster Session

 

4:20 - 5:35

Title

Speaker

Company

Time

Registration

 

7:30 - 8:30

Workshop Introduction

Christopher Kochansky

Exelixis

8:30 - 8:40

Session I: Biomarkers & Multi-Omics Data Integration for Biomarker Discovery

Session Introduction: Jonnathan Josephs, Genentech & Zac Parsons, BMS

 

 

8:40 - 8:45

Plenary Talk - Quantitative Mass Spectrometry-based Multi-omics for Drug Development and Precision Medicine

Bhagwat Prasad

Washington State University

8:45 - 9:25

Multi-omics Analysis of Colon Mucosa and Wall from Crohn’s Disease Patients

Liang Jin

AbbVie

9:25 - 9:55

Mass Spectrometry CSF Proteomics and Single-cell Sequencing to Identify Novel Biomarkers in Multiple Sclerosis

Akshaya Ramesh

Genentech

9:55 - 10:25

AM Break

10:25 - 10:55

Session II: Precision Medicine Applications

Session Introduction: Hiroshi Sugimoto, Takeda & Yu Tian, AbbVie

 

 

10:55 - 11:00

NanoString-based high throughput micro RNA biomarker assay development

Saran Ayyadurai

Takeda

11:00 - 11:30

Title TBA

Qin Jin

AbbVie

11:30 - 12:00

Title TBA

TBA

TBA

12:00 - 12:30

Lunch

 

12:30 - 2:00

Sponsor Showcase

2:00 - 2:20

Session III: DMPK/Bioanalysis of PROTACS/Protein Degraders/Protein Peptides

Session Introduction: John Williams, Vertex & Jeongsup Shim, Genentech

 

 

2:20 - 2:25

Investigating Permeability for Heterobifunctional Protein Degraders

Joe Cannon

BMS

2:25 - 2:55

Bioanalytical Strategies for Characterization and PK Assessment of Multi-specific Antibodies

Yue-Ting Wang

AbbVie 

2:55 - 3:25

PM Break

 

3:25 - 3:55

Title TBA

Andreas Harsch

Kymera Therapeutics 

3:25 - 4:25

Session IV: Vendor Session - Latest Advances in LC-MS

     

Session Introduction: Hongying Gao, Innovo Bioanalysis LLC & Christopher Kochansky, Exelixis & Jonathan Josephs, Genentech

 

 

4:25 - 4:30

Bruker/Waters/Sciex/Thermo/Shimadzu/Phenomenex/Molecular Discovery

4:30 - 5:10

Closing Remarks

5:10 - 5:15

Title

Speaker

Company

Time

Registration

 

7:30 - 8:30

Workshop Introduction

Benjamin Johnson

BMS

8:30 - 8:40

Session I: ADME of Select Modalities

Session Introduction: Nagendra Chemuturi, Moderna & Cindy Xia, Renegade Therapeutics

 

 

8:40 - 8:45

Title TBA

Steven Louie

Novartis

8:45 - 9:10

Title TBA

Upendra Dahal

Amgen

9:10 - 9:35

Title TBA

Lei Ci

Moderna

9:35 - 10:00

Break


10:00 - 10:25

Sponsor Showcase

10:25 - 10:45

Session II: Unexpected ADMET Profiles in the Clinic and Investigations into Root Causes

     

Session Introduction: Benjamin Johnson, BMS & Greg Walker, Pfizer

 

 

10:45 - 10:50

Title TBA

TBA

TBA

10:50 - 11:15

Title TBA

TBA

TBA

11:15 - 11:40

Title TBA

TBA

TBA

11:40 - 12:05

Lunch

 

12:05 - 1:20

Plenary Speaker Introduction     1:20 - 1:25

Plenary Talk - Title TBA

Sekhar Surapaneni

1:25 - 2:05

Session III: New Technology in ADME

Session Introduction: Donglu Zhang, Genentech & David Stresser, AbbVie

 

 

2:05 - 2:10

Title TBA

Edward Price

AbbVie

2:10 - 2:35

Title TBA

TBA

TBA

2:35 - 3:00

Mathematical Models to Characterize the Absorption, Distribution, Metabolism, and Excretion of Protein Therapeutics

Dhaval K. Shah

University at Buffalo

3:00 - 3:25

PM Break

3:25 - 3:45

Session IV: Unusual Biotransformation Pathways

     

Session Introduction: James Driscoll, BMS & Eric Ballard, Takeda

 

 

3:45 - 3:50

Title TBA

TBA

TBA

3:50 - 4:15

Title TBA

Simone Schadt

Roche

4:15 - 4:40

Conference Closing Remarks

 

4:40- 4:45

Workshops

Regulated Bioanalysis

Discovery

Mechanistic ADME

Registration

Click here to register for the APA 2023 conference.

APA 2023 will take place September 26-28, 2023

Merck Research Laboratories, Boston, MA

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy